SPP Spring 2019 Meeting
March 15^th - 17th, 2019 
Crystal Gateway Marriott
(within driving distance of National Harbor, MD) 

Airport Transportation Information
The Crystal Gateway Marriott is about 2 miles northwest from the Ronald Regan Washington National Airport (DCA). Complimentary Shuttle from Reagan Washington National Airport from 6:05am to 11:00pm, pickup locations are the A Gates and Doors 5 and 9, in the B and C Concourse Lower Level. 

Air Travel
Delta Air Lines is offering special discounted* airfares for SPP Spring 2019 Meeting attendees traveling to Arlington. Discounts vary, depending on the class of ticket purchased, up to 10% off the fare. *Please note the following:

• Not all fare codes are eligible for a discount; fare rules determine eligibility
• Discounts vary, depending on the class of ticket purchased, and apply to round trip travel only.
• Not valid with any other discounts, certificates, coupons or promotional offers.
• Name changes on the ticket are permitted at $200 USD/$200 CAD on select fares.

To take advantage of these Travel Discounts for flights to and from the US:

• Visit the www.delta.com website and click the Advanced Search link
• Complete the required fields, and enter meeting code “NMSE9”
• You may also call Delta Meeting Network® Reservations at +1-800-328-1111 (Please use the same phone number to make changes to an existing Delta Meetings Network reservation.)
• On the Search Results page, verify the discount is applied.  (reminder: not all fare codes are eligible)

Car Rental

SPP Spring 2019 Meeting attendees can enjoy savings of up to 25% off Budget base rates when renting a vehicle from a participating location in the contiguous U.S. and Canada. Use Budget Customer Discount (BCD) number D958401 to shop the lowest rates for your next rental. For online reservations, click here.

Car Service

SPP Spring 2019 Meeting attendees can order a car service through Carey. To book a car, you will need to create an account with Carey. After creating an account and entering your travel details, you can apply a promo code (KLATAS) to receive a discounted rate. 

Quicklinks

Registration for the 2019 SPP Spring Meeting is now closed. You may register onsite at the meeting.

PLEASE NOTE: BOTH hotel blocks expired on Wednesday, February 20, 2019
The hotel reservations websites are now closed. Those needing hotel reservations should contact the hotels directly to reserve rooms. They should continue to identify themselves as SPP attendees so they can be accounted for in our block, but it is at the hotels’ discretion to honor the contracted room rates.
Crystal  Gateway Marriott: +1-703-920-3230
Westin Crystal City: +1 703-486-1111

2019 SPP Registered Attendees

2019 Mobile App Instructions

2019 SPP Spring Meeting Program Book

2019 SPP Spring Meeting Abstract Book 

2019 SPP Spring Meeting Preliminary Agenda

2019 SPP Spring Meeting Exhibitor Information

USCAP Specialty Evening Event
USCAP would like to extend an invitation for SPP members to complementarity attend the 2019 Pediatric Evening Specialty Conference held on Sunday, March 17, from 7:00 – 9:00PM. SPP members wishing to attend this event will need to check in at the main registration desk and ask for a one-time guess pass.

2018 SPP Spring Meeting - Annual Business Meeting Minutes

2019 SPP Spring Meeting - Annual Business Meeting Agenda

SPP COMMITTEE MEETINGS
Spring 2019
Crystal Gateway Marriott
1700 Jefferson Davis Highway
Arlington, VA 22202

Friday, March 15th, 2019
8:00 a.m. – 10:00 a.m.         Executive Committee and Strategic Planning Meeting (closed) Room: Arlington Salon 1
10:00 a.m. – 11:30 a.m.       Finance Committee Meeting (open) Room: Arlington Salon 1
11:30 a.m. – 1:00 p.m.         PDP Editorial Board Meeting with Lunch (by invitation) Room: Pentagon    
1:00 p.m. – 3:00 p.m.           Publications Committee (open) Room: Manassas
1:00 p.m. – 3:00 p.m.           Fellowship Committee (open) Room: Jackson
1:00 p.m. – 3:00 p.m.           Research and Awards Committee (closed) Room: McLean
1:00 p.m. – 4:00 p.m.           Education Committee Meeting (closed) Room: Mt. Vernon
3:00 p.m. – 4:00 p.m.           Perinatal Committee (open) Room: Manassas
3:00 p.m. – 4:00 p.m.           Practice Committee (open) Room: Jackson
3:00 p.m. – 4:00 p.m.           Membership Committee (open) Room: McLean
4:00 p.m. – 6:30 p.m.           Slide Survey Subcommittee Working Meeting (closed) Room: Mt. Vernon
4:00 p.m. – 6:30 p.m.           Board of Directors Meeting (by invitation) Room: Arlington Salon 1

New! CME Early morning interactive sessions: 

Saturday, March 16, 2019, 7:00 a.m. - 8:00 a.m.: Soft Tissue Tumors and Next Generation Testing: Integration of Histological and Molecular Findings, David Parham, MD, Children's Hospital in Los Angeles

At the end of this presentation, participants should be able to:

1. Identify key histological features of pediatric sarcomas that lead to diagnostic ancillary testing.
2. Apply and critique immunohistochemical testing for surrogate markers of pediatric gene fusions.
3.  Appraise and demonstrate the use of next generation sequencing in the diagnosis of pediatric sarcomas.

Sunday, March 17, 2019, 7:00 a.m. - 8:00 a.m.: The Transition From an Academic to a Leadership Career in Pathology, Megan Delaney, DO, MPH, Children's National Health System 

At the end of this presentation, participants should be able to:

1. Distinguish some of the essential skills for leadership positions in pathology.
2. Differentiate how leadership positions differ from other roles
3. Formulate steps in your career that may prepare you for a leadership position.

Schedule of Events:

Committee Meetings – March 15^th, 2019 

Scientific and Educational Sessions – March 16^th, 2019 and March 17^th, 2019

Symposium: “Lymph Node Pathology for the Pediatric Pathologist" 
Andrea N. Marcogliese MD, Baylor College of Medicine, M. Kamran Mirza, MD PhD, Loyola University Medical Center, Aliya N. Husain, MD, University of Chicago, Kevin E. Fisher, MD, PhD, Texas Children’s Hospital, Carl Allen MD, PhD, Texas Children's Cancer Center 

At the end of this presentation, participants should be able to:

• Identify the 2016 updates to pediatric lymphomas and lymphoproliferative disorders in the WHO classification of pediatric hematologic malignancies
• Use touch preparations and review fine needle aspirate smears to accurately assess lymphoid tissue and select appropriate testing to make a diagnosis and make best use of tissue, especially when limited, and utilize a comprehensive yet cost effective approach to the diagnosis of lymphoid lesions
• Integrate molecular diagnostic data into diagnostic algorithms and appropriately order and interpret test results in the context of a diagnostic work up of lymphoma and select appropriate ancillary studies that identify potential prognostic and/or therapeutic markers relevant to lymphomas
  
  Workshop Session I
  
  A. Year 1/3: Role of Bias in Pediatric Pathology: Preventing Errors and Enhancing Patient Safety One Child at a Time. Vinay Prasad, MD, Monroe Carrell Jr. Children's Hospital at Vanderbilt, Kathleen Nicol, MD, Nationwide Children's Hospital, The Ohio State University
  

  This is an ABPath approved Patient Safety Course, and would carry Improvement in Medical Practice credit in addition to CME and SAM credits to participants who fulfill the CME and SAM requirements

At the end of this presentation, participants should be able to:

• Identify different cognitive biases that can cause errors
• Participants will be able to utilize de-biasing strategies, thereby preventing errors
• Participants will understand the dual processing system that we use every day, and utilize their understanding of Type 1 (intuitive) and Type 2 (analytic) processes to avoid errors and failure.

B. Year 2/3: Bone dysplasias: A systematic diagnostic approach - Linda Ernst, MD, Northshore University Healthsystem, Evanston Hospital and Peter Nikkels, MD, University Medical Center Utrecht, Netherlands         

At the end of this presentation, participants should be able to:

• Describe the diagnostic histological aspects of some common skeletal dysplasia’s recognizable at birth.
• Describe the diagnostic features of the X-rays of several common skeletal dysplasias recognizable at birth.
• Recognize the limitations of histology to diagnose a skeletal dysplasia.
• Use a diagnostic scheme to diagnose the more common skeletal dysplasia’s recognizable at birth.

C. Year 3/3: Pediatric Gastrointestinal Biopsy: An Update on the Diagnosis and Pathogenesis of Pediatric Upper Gastrointestinal Disease - Amy Lowichik, MD, PhD, University of Utah School of Medicine, Salt Lake City, UT and Raul S. Gonzalez, MD, University of Rochester Medical Center, Rochester, NY                                               

At the end of this presentation, participants should be able to:

• Recognize the inflammatory findings characteristic of allergic and autoimmune diseases of the pediatric upper gastrointestinal tract.
• Describe the histologic criteria for pre-malignant and malignant lesions of the pediatric upper gastrointestinal tract.
• Order and recommend appropriate ancillary testing for common and rare developmental, allergic, autoimmune, pre-malignant and malignant lesions of the pediatric upper gastrointestinal tract. 

Workshop Session II

D. Year 1/3: What Can the Placenta Tell Us? Debra S. Heller, MD, Rutgers-New Jersey Medical School, Rebecca N. Baergen, MD, Weill Cornell Medical College – New York Presbyterian Hospital

At the end of this presentation, participants should be able to:

• Diagnose placental lesions with a risk of recurrence in future pregnancies
• Diagnose placental lesions associated with neurologic injury and stillbirth
• Understand the terminology used in placental pathology including the Amsterdam Placental Workshop Guidelines
  
  E. Year 2/3: What every pediatric pathologist needs to know: WHO Classification of Tumors of the Central Nervous System (2016) Pediatric Tumors – Alexander Judkins, MD, Children's Hospital Los Angeles and Cynthia Hawkins, MD, Hospital for Sick Children, Toronto and Mariarita Santi, MD, Children's Hospital of Philadelphia             
  

At the end of this presentation, participants should be able to:  

Cynthia Hawkins:

• Apply the 2016 WHO Classification of Tumors of the Central Nervous System to the diagnosis of medulloblastoma
• Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of medulloblastoma
• Apply immunohistochemical and molecular techniques to determine medulloblastoma molecular subgroup
• Appreciate the clinical relevance of molecular subgrouping and TP53 mutation status in medulloblastoma
  
  Alexander Judkins:
• Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma)
• Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma).
• Distinguish AT/RT lacking histological features of rhabdoid differentiation from other pediatric CNS embryonal tumors on the basis of immunohistochemistry and/or molecular analysis of SMARCB1/INI1 and/or SMARCA4/BRG1.
• Using their molecular profile, distinguish C19MC-altered embryonal tumors from other pediatric embryonal CNS tumors.
  
  Mariarita Santi:
  
  
• Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric glial tumors
• Approach the diagnosis of pediatric glial brain tumors using a combination of morphology and molecular diagnostic techniques
• Distinguish the BRAF mutated glial tumors from the Histone-3 mutated tumors and extrapolate the prognostic implications.
• Separate the molecular profile of supratentorial ependymomas from the infratentorial
• Integrate morphologic and molecular results into a comprehensive pathology report.

F. Year 3/3: Challenges in Pediatric Soft Tissue Pathology: A Case-Based Approach to Selected Difficult Cases- Jennifer Black, MD, University of Colorado Anschutz School of Medicine, Children’s Hospital Colorado, Aurora, Colorado and Erin R. Rudzinski, MD; Seattle Children’s Hospital, Seattle, Washington                           

At the end of this presentation, participants should be able to:

• Describe the distinguishing features and the differential diagnosis for frequently encountered pediatric soft tissue lesions and their histologic mimics.
• Select appropriate ancillary tests to confirm diagnosis, including a strategic panel of immunohistochemical stains, electron microscopy, conventional cytogenetics analysis and molecular genetic testing.
• Create a pathology report including all essential information for the diagnosis of an intermediate or malignant soft tissue lesion to facilitate further patient management.

The Society for Pediatric Pathology is soliciting proposals for the 2020, 2021 and 2022 SPP Fall Meeting host institutions.

The Society holds a Fall Meeting each year at various pediatric institutions throughout North America; this Meeting includes the presentation of scientific abstracts, and a symposium that draws upon the expertise of local faculty, and a separate symposium on a perinatal topic. An informal atmosphere allows for interchange among colleagues and an opportunity to visit the institutions of peers.

If you are interested in submitting a proposal, please read the Host Responsibilities document and submit your proposal via email to Patricia Ferchland-Bingham. If you're planning to propose a meeting, please specify which on the proposal form. 

Program Overview

• Spring 2020 Meeting: Los Angeles, CA, Februrary 28 - March 1, 2020
• Fall 2020 Meeting: Portland, OR, dates TBA
• Spring 2021 Meeting: Baltimore, MD, March 13 - 15, 2021
• Spring 2022 Meeting: Los Angeles, CA, March 19 - 21, 2022
• Spring 2023 Meeting: New Orleans, LA, March 11 - 13, 2023